BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 34111583)

  • 1. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.
    Lim C; Ashley EA; Hamers RL; Turner P; Kesteman T; Akech S; Corso A; Mayxay M; Okeke IN; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Infect; 2021 Oct; 27(10):1391-1399. PubMed ID: 34111583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.
    Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C
    Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries.
    Gandra S; Alvarez-Uria G; Turner P; Joshi J; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Rev; 2020 Sep; 33(3):. PubMed ID: 32522747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening.
    Joh HS; Yeats C; Shaw A; Poudyal N; Gallagher P; Kim JH; Shaikh A; Seo HJ; Chi KK; Prifti K; Cho A; Sujan MJ; Eraly E; Pham KD; Shrestha S; Aboushady AT; Pak G; Jang G; Park EL; Seo HW; Abudahab K; Taylor BEW; Clark A; Dolabella B; Yoon H; Han J; Kwon SY; Marks F; Stelling J; Aanensen DM; MacWright WR; Holm M
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S507-S518. PubMed ID: 38118007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filling the gaps in the global prevalence map of clinical antimicrobial resistance.
    Oldenkamp R; Schultsz C; Mancini E; Cappuccio A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33372157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling.
    Ginting F; Sugianli AK; Bijl G; Saragih RH; Kusumawati RL; Parwati I; de Jong MD; Schultsz C; van Leth F
    Am J Epidemiol; 2019 Apr; 188(4):734-742. PubMed ID: 30608516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries.
    Graells T; Lambraki IA; Cousins M; Léger A; Henriksson PJG; Troell M; Carson CA; Parmley EJ; Majowicz SE; Wernli D; Jørgensen PS
    Front Public Health; 2023; 11():1230848. PubMed ID: 37900049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis.
    Lewnard JA; Charani E; Gleason A; Hsu LY; Khan WA; Karkey A; Chandler CIR; Mashe T; Khan EA; Bulabula ANH; Donado-Godoy P; Laxminarayan R
    Lancet; 2024 Jun; 403(10442):2439-2454. PubMed ID: 38797180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans.
    Schrijver R; Stijntjes M; Rodríguez-Baño J; Tacconelli E; Babu Rajendran N; Voss A
    Clin Microbiol Infect; 2018 Jun; 24(6):577-590. PubMed ID: 28970159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The barriers and facilitators of implementing a national laboratory-based AMR surveillance system in Cambodia: key informants' perspectives and assessments of microbiology laboratories.
    Mao S; Soputhy C; Lay S; Jacobs J; Ku GM; Chau D; Chhea C; Ir P
    Front Public Health; 2023; 11():1332423. PubMed ID: 38179556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbiased antimicrobial resistance prevalence estimates through population-based surveillance.
    van Leth F; Schultsz C
    Clin Microbiol Infect; 2023 Apr; 29(4):429-433. PubMed ID: 35595126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMR in low-resource settings: Médecins Sans Frontières bridges surveillance gaps by developing a turnkey solution, the Mini-Lab.
    Ronat JB; Natale A; Kesteman T; Andremont A; Elamin W; Hardy L; Kanapathipillai R; Michel J; Langendorf C; Vandenberg O; Naas T; Kouassi F
    Clin Microbiol Infect; 2021 Oct; 27(10):1414-1421. PubMed ID: 33932617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Drivers of Antimicrobial Resistance across the World.
    Vikesland P; Garner E; Gupta S; Kang S; Maile-Moskowitz A; Zhu N
    Acc Chem Res; 2019 Apr; 52(4):916-924. PubMed ID: 30848890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility.
    Sharma A; Singh A; Dar MA; Kaur RJ; Charan J; Iskandar K; Haque M; Murti K; Ravichandiran V; Dhingra S
    J Infect Public Health; 2022 Feb; 15(2):172-181. PubMed ID: 34972026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for surveillance of antimicrobial-resistant bacteria causing community-acquired urinary tract infections in low-income countries.
    Majigo MV; Mshana S; Komba E; Moremi N; Matee M
    PLoS One; 2024; 19(5):e0304388. PubMed ID: 38820392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
    J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome sequencing as part of national and international surveillance programmes for antimicrobial resistance: a roadmap.
    NIHR Global Health Research Unit on Genomic Surveillance of AMR
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33239336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global surveillance of antimicrobial resistance and hypervirulence in Klebsiella pneumoniae from LMICs: An in-silico approach.
    Silvester R; Madhavan A; Kokkat A; Parolla A; B M A; M H; Abdulla MH
    Sci Total Environ; 2022 Jan; 802():149859. PubMed ID: 34464800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.